Cymat Technologies Ltd. CYMHF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.07M | 619.00K | 443.40K | 181.80K | 140.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.07M | 619.00K | 443.40K | 181.80K | 140.10K |
| Cost of Revenue | 850.10K | 562.00K | 413.30K | 97.30K | 307.90K |
| Gross Profit | 219.40K | 56.90K | 30.00K | 84.50K | -167.70K |
| SG&A Expenses | 418.30K | 523.50K | 456.80K | 602.10K | 413.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30M | 1.11M | 898.50K | 751.70K | 752.50K |
| Operating Income | -227.00K | -495.30K | -455.10K | -569.90K | -612.40K |
| Income Before Tax | -680.00K | -1.17M | -778.50K | -718.90K | -866.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -680.00K | -1.17M | -778.50K | -718.90K | -866.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -680.00K | -1.17M | -778.50K | -718.90K | -866.10K |
| EBIT | -227.00K | -495.30K | -455.10K | -569.90K | -612.40K |
| EBITDA | -200.40K | -461.80K | -363.20K | -481.20K | -522.60K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 100.34M | 100.64M | 98.53M | 85.99M | 77.54M |
| Average Diluted Shares Outstanding | 100.34M | 100.64M | 98.53M | 85.99M | 77.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |